Clovis Oncology (CLVS) is engaged in acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. This stock closed up 16.68% at $54.56 in Wednesday's trading session.
Wednesday's Volume: 1.12 million
Three-Month Average Volume: 443,143
Volume % Change: 130% P/>>>5 Big Stocks to Trade Big Gains
From a technical perspective, CLVS skyrocketed higher here back above its 200-day moving average of $50.95 with above-average volume. This move pushed shares of CLVS into breakout territory, since the stock took out some near-term overhead resistance at $53.35. Shares of CLVS are now quickly moving within range of triggering another big breakout trade. That trade will hit if CLVS manages to take out Wednesday's high of $54.97 to its 50-day moving average of $56.82 with high volume.Traders should now look for long-biased trades in CLVS as long as it's trending above its 200-day at $50.95 and then once it sustains a move or close above those breakout levels with volume that hits near or above 443,143 shares. If that breakout hits soon, then CLVS will set up to re-test or possibly take out its next major overhead resistance levels at $64 to $65. Biomarin Pharmaceutical Biomarin Pharmaceutical (BMRN) develops and commercializes pharmaceuticals for serious diseases and medical conditions. This stock closed up 3.3% at $69.14 in Wednesday's trading session. Wednesday's Volume: 4.40 million
Three-Month Average Volume: 1.88 million
Volume % Change: 107% From a technical perspective, BMRN spiked higher here right off its 50-day moving average of $68.62 with strong upside volume. This stock has been uptrending strong for the last few weeks, with shares moving higher from its low of $58.65 to its intraday high of $71.76. During that move, shares of BMRN have been consistently making higher lows and higher highs, which is bullish technical price action. Market players should now look for a continuation move higher in the short-term if BMRN can take out Wednesday's high of $71.76 with strong volume. Traders should now look for long-biased trades in BMRN as long as it's trending above its 50-day at $68.62 or above $67.50 and then once it sustains a move or close above $71.76 with volume that this near or above 1.88 million shares. If we get that move soon, then BMRN will set up to re-test or possibly take out its next major overhead resistance levels at $76 to its 52-week high at $80.67. ANI Pharmaceuticals ANI Pharmaceuticals (ANIP) is a specialty pharmaceutical company engaged in the development of products for female sexual health, menopause, contraception and male hypogonadism. This stock closed up 6.8% at $13.45 in Wednesday's trading session. Wednesday's Volume: 125,000
Three-Month Average Volume: 64,660
Volume % Change: 106% From a technical perspective, ANIP spiked sharply higher here into new 52-week high territory with strong upside volume. This stock has been uptrending strong for the last two months and change, with shares moving higher from its low of $6.84 to its intraday high of $13.49. During that uptrend, shares of ANIP have been making mostly higher lows and higher highs, which is bullish technical price action. Traders should now look for long-biased trades in ANIP as long as it's trending above its recent breakout level of $12 and then once it sustains a move or close above its new 52-week high at $13.49 with volume that's near or above 64,660 shares. If we get that move soon, then ANIP will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $17 to $20. To see more stocks rising on unusual volume, check out the Stocks Rising on Unusual Volume portfolio on Stockpickr. -- Written by Roberto Pedone in Delafield, Wis.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV